HKSE · 0575.HK
Regent Pacific Group Limited
HK$0.87+HK$0.02 (+2.35%)
Regent Pacific Group Limited’s quoted price sits in the lower half of its reported 52-week range, 28.69% below the high.
Loading market information…
HKSE · 8158.HK · HKD
Stock price, dividends, earnings
Quote as of Oct 30, 2026, 05:00 AM UTC. Cached market data; not a live quote.
One-year closing-price history · HKD. Historical prices are not a forecast.
China Regenerative Medicine International Limited’s quoted price sits in the lower half of its reported 52-week range, 62.88% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
China Regenerative Medicine International Limited’s forward annual dividend is HK$1.20 per share, paid monthly. The forward yield is 489.8% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow China Regenerative Medicine International Limited’s reporting calendar.
THE COMPANY BEHIND THE TICKER
China Regenerative Medicine International Limited operates as an investment holding entity, focusing on the development and distribution of a diverse portfolio of healthcare products and associated services. The company provides extensive health management solutions, covering health condition assessments, detoxification programs, fostering internal bodily balance, nourishing vital organs, and enhancing the immune system. Additionally, its beauty offerings encompass non-surgical medical aesthetics, essential dermatological care, anti-aging skin remedies, hair revitalization, skin firming treatments, localized body contouring, and intimate restoration services. Established in 1995, the organization was previously known as China Bio-Med Regeneration Technology Limited until its rebranding to China Regenerative Medicine International Limited in March 2015. Its headquarters are situated in Tsim Sha Tsui, Hong Kong.
Latest available per-share figures in HKD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 05:01 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
HK$0.87+HK$0.02 (+2.35%)
Regent Pacific Group Limited’s quoted price sits in the lower half of its reported 52-week range, 28.69% below the high.
HK$0.41-HK$0.02 (-4.71%)
Bamboos Health Care Holdings Limited’s quoted price sits in the lower half of its reported 52-week range, 30.17% below the high.
HK$0.05HK$0.00 (0.0%)
Extrawell Pharmaceutical Holdings Limited’s quoted price sits in the lower half of its reported 52-week range, 55.65% below the high.
HK$0.23-HK$0.00 (-0.86%)
PuraPharm Corporation Limited’s quoted price sits in the lower half of its reported 52-week range, 47.73% below the high.
HK$0.65-HK$0.08 (-10.96%)
King International Investment Limited’s quoted price sits in the lower half of its reported 52-week range, 59.12% below the high.
HK$0.19-HK$0.02 (-10.38%)
Kelfred Holdings Limited’s quoted price sits in the lower half of its reported 52-week range, 65.45% below the high.
HK$0.07+HK$0.00 (+4.76%)
China Health Group Inc.’s quoted price sits in the lower half of its reported 52-week range, 59.76% below the high.
HK$0.07-HK$0.00 (-1.35%)
China Healthwise Holdings Ltd.’s quoted price sits in the lower half of its reported 52-week range, 80.0% below the high.
